Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000300·AVADEL PHARMACEUTICALS PLC
Schedule 13G ownership disclosure
AVADEL PHARMACEUTICALS PLC
Common Stock · CUSIP: G29687103
Event date: 2025-09-30
- Filing-level shares
- 7,429,718
- Percent of class
- 7.7%
- JANUS HENDERSON GROUP PLC
Shares: 7,429,718 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000300
- Form type
- SCHEDULE 13G/A
- Filer
- AVADEL PHARMACEUTICALS PLC
- CIK
- CIK 1012477
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership